Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development

Despite decades of effort in understanding pancreatic ductal adenocarcinoma (PDAC), there is still a lack of innovative targeted therapies for this devastating disease. Herein, we report the expression of apelin and its receptor, APJ, in human pancreatic adenocarcinoma and its protumoral function. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves-Almagro, Carline, Auriau, Johanna, Dortignac, Alizée, Clerc, Pascal, Lulka, Hubert, Deleruyelle, Simon, Projetti, Fabrice, Nakhlé, Jessica, Frances, Audrey, Berta, Judit, Gigoux, Véronique, Fourmy, Daniel, Dufresne, Marlène, Gomez-Brouchet, Anne, Guillermet-Guibert, Julie, Cordelier, Pierre, Knibiehler, Bernard, Jockers, Ralf, Valet, Philippe, Audigier, Yves, Masri, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503500/
https://www.ncbi.nlm.nih.gov/pubmed/36142542
http://dx.doi.org/10.3390/ijms231810600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503500/
https://www.ncbi.nlm.nih.gov/pubmed/36142542
http://dx.doi.org/10.3390/ijms231810600

Ejemplares similares